transcarent.aiHealthcare / Healthcare providers & servicesFounded: 2018Funding to Date: $1.1B
Transcarent is a digital health company that offers a healthcare technology platform striving to simplify and improve healthcare experiences and outcomes for employers and their employees. The company’s mission is to provide high-quality, affordable, and accessible care. Transcarent was founded in 2020 and is headquartered in Denver, CO. Transcarent also has a consumer-facing mobile app, an on-demand care team, and a network of pre-screened healthcare providers with which the company has direct contracts.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
03/07/2024 | Series D | $150MM | $xx.xx | $1.87B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
7,325,631
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
01/11/2022 | Series C | $200MM | $xx.xx | $1.62B | 7wireventures, Ally Bridge Group, Alta Partners, General Catalyst, Greatpoint Ventures, Human Capital, Intermountain Healthcare, Jove Equity Partners, Kinnevik, Merck Global Health Innovation Fund, Northwell Health, Rush University Medical Center, Threshold Ventures | |
Price per Share
$xx.xx
Shares Outstanding
10,521,808
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
7wireventures, Ally Bridge Group, Alta Partners, General Catalyst, Greatpoint Ventures, Human Capital, Intermountain Healthcare, Jove Equity Partners, Kinnevik, Merck Global Health Innovation Fund, Northwell Health, Rush University Medical Center, Threshold Ventures
|
||||||
06/10/2021 | Series B | $58MM | $xx.xx | $468.55MM | 7wireventures, Alta Partners, General Catalyst, Greatpoint Ventures, Jove Equity Partners, Kleiner Perkins, Leaps Bybayer, Merck Global Health Innovation Fund, Threshold Ventures | |
Price per Share
$xx.xx
Shares Outstanding
9,589,915
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
7wireventures, Alta Partners, General Catalyst, Greatpoint Ventures, Jove Equity Partners, Kleiner Perkins, Leaps Bybayer, Merck Global Health Innovation Fund, Threshold Ventures
|
||||||
10/22/2020 | Series A-2 | $163,838.15 | $xx.xx | $231.54MM | 7wire Ventures, Alta Partners, General Catalyst, Jove Equity Partners | |
Price per Share
$xx.xx
Shares Outstanding
167,371
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
7wire Ventures, Alta Partners, General Catalyst, Jove Equity Partners
|
||||||
10/22/2020 | Series A | $25.89MM | $xx.xx | $231.54MM | 7wire Ventures, Alta Partners, General Catalyst, Jove Equity Partners | |
Price per Share
$xx.xx
Shares Outstanding
15,148,291
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
7wire Ventures, Alta Partners, General Catalyst, Jove Equity Partners
|
||||||
10/22/2020 | Series A-1 | $13.95MM | $xx.xx | $231.54MM | 7wire Ventures, Alta Partners, General Catalyst, Jove Equity Partners | |
Price per Share
$xx.xx
Shares Outstanding
4,389,220
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
7wire Ventures, Alta Partners, General Catalyst, Jove Equity Partners
|
||||||
08/15/2018 | Series Seed | $3MM | $xx.xx | $30.8MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
6,000,000
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
08/15/2018 | Series Seed-2 | $3.37MM | $xx.xx | $30.8MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
3,440,641
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|